期刊文献+

中国18家医院2008-2012年肾癌诊治现状分析 被引量:21

A comprehensive analysis of the management of renal cell carcinoma in 18 Chinese hospitals from 2008 to 2012
原文传递
导出
摘要 目的 统计全国18家医院泌尿外科2008-2012年肾癌患者的诊治资料,分析肾癌发病情况及诊治观念的变化. 方法 统计2008年1月至2012年12月全国18家医院泌尿外科收治肾癌患者的临床资料,对患者的年龄、性别、地域分布、手术方式、术后病理类型、住院日及治疗费用等资料进行分析. 结果 18家医院5年共收治9 725例肾癌患者,其中6 853例具备较完整的临床资料.男4 529例,女2 324例,男女比例为1.95∶1.00.发病年龄1~99岁,平均(56.0±13.3)岁,中位年龄56.0岁.华东及华北地区诊治病例数分别为3 422例及2 153例,多于其他地区.病理类型以透明细胞癌为主,为3 517例(51.32%).6 853例患者中行腹腔镜手术者2495例(36.41%),开放性手术3 891例(56.78%),其他治疗467例(6.81%).手术病例中保留肾单位手术1 935例(30.30%),根治性手术4451例(69.70%).患者总住院时间(16.8±7.8)d,治疗费用为(22 059±9 722)元. 结论 我国肾癌病理类型仍以透明细胞癌为主,手术仍然是主要的治疗手段,腹腔镜手术及保留肾单位手术所占权重在逐渐增加. Objective To analyze the demographic and clinical data of patients with renal cell carcinoma (RCC) in 18 hospitals throughout China between 2008 and 2012,and to assess the change of concept in RCC management.Methods Demographic and clinical data of RCC patients managed in urology department of 18 hospitals in China was collected and analyzed,including age,gender,type of surgical procedure,surgical pathology,length of hospital-stay,cost of treatment,and geographical distribution.Results A total of 9 725 RCC cases were managed throughout the 5 years in 18 hospitals,among which 6 853 cases had full records,including 4 529 males and 2 324 females,with a male to female ratio of 1.95 ∶ 1.00.Age of presentation ranged from 1 to 99 years,with an average of 56.0 years.The number of the patients in East China and North China were 3 422 and 2 153.Clear cell RCC was the predominant type of pathology,with a total of 3 517 cases (51.32%).Among all the 6 853 patients,there were 2495 cases of laparoscopic surgery (36.41%),3 891 cases of open surgery (56.78%),and 467 others (6.81%).1 935 patients (30.30%) received nephron-sparing surgery,while 4 451 patients (69.70%) had radical nephrectomy.The total length of hospital-stay was (16.8 ± 7.8) d,with the cost of (22 059 ± 9 722) RMB.Conclusions Clear cell RCC is the predominant pathological subtype of RCC.Surgery as always has been the main choice of treatment,with the proportion of laparoscopic surgery and nephron-sparing surgery gradually increasing.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2014年第6期406-409,共4页 Chinese Journal of Urology
关键词 肾细胞 多中心 病理学 临床 诊断 治疗 Carcinoma,renal cell Multi-center Pathology,clinical Diagnosis Treatment
  • 相关文献

参考文献14

  • 1马建辉,李鸣,张思维,那彦群,陈万青.中国部分市县肾癌及泌尿系其他恶性肿瘤发病趋势比较研究[J].中华泌尿外科杂志,2009,30(8):511-514. 被引量:53
  • 2李鸣,何志嵩,高江平,孙颖浩,李长岭,黄翼然,孙光,王国民.多中心肾癌临床特征分析[J].中华泌尿外科杂志,2010,31(2):77-80. 被引量:76
  • 3顾方六,肾肿瘤[M]//吴阶平.泌尿外科学.上卷.济南:山东科学技术出版社,2004:895-896.
  • 4赵文华.恶性肿瘤流行趋势分析及预防的研究[J].天津科技,2006,33(3):38-39. 被引量:37
  • 5马建辉,何志嵩.肾细胞癌诊断治疗指南[M] //那彦群,孙光.中国泌尿外科疾病诊断治疗指南.2009版.北京:人民卫生出版社,2009:4-15.
  • 6Eble JN, Sauter G, Epstein JI, et al. Pathology and genetics of tumours of the urinary system and male genital organs [ M ]. Lyon: IARC, 2004: 12-43.
  • 7Krabbe LM, Bagrodia A, Margulis V, et at. Surgical management of renal cell carcinoma [ J]. Semin Intervent Radiol, 2014, 31: 27-32.
  • 8Jung JH, Kim HW, Oh CK, et at. Simultaneous robot-assisted lapsroendoscopic single-site partial nephreetomy and standard radical prostatectomy [ J]. Yonsei Med J, 2014, 55: 535-538.
  • 9Bigot P, Hettet JF, Bernhard JC, et al. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and func- tional and oncological outcomes [ J]. Clin Genitourin Cancer, 2014, 12: 19-27.
  • 10Fergany AF, Hafez KS, Novick AC. Long term results of nephron sparing surgery for localized renal cell carcinoma: 10 year follow- up [J]. J Urol, 2000, 163: 442-445.

二级参考文献39

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon:IARC, 1991:101 -107.
  • 6Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon: IARC, 1994: 35 -49.
  • 7Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005:11 38.
  • 8Felay J. The IARCcrgTools program, http://www, iacr. com. fr/ iarccrgtools, htm. IACR. Lyon. 2006.
  • 9Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. Ⅷ. IARC Scientific Publication No. 155. Lyon:IARC, 2002: 745-747.
  • 10Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.

共引文献189

同被引文献144

  • 1兰晓鹏,蒋伟,孙桢,王正,金讯波,夏庆华.各年龄段(青年、中年、老年)肾癌患者临床特征及诊治分析[J].泌尿外科杂志(电子版),2013,5(4):4-8. 被引量:13
  • 2Jordi Muntané,Manuel De la Mata.Nitric oxide and cancer[J].World Journal of Hepatology,2010,2(9):337-344. 被引量:9
  • 3Nazim SM;Ather MH;Hafeez K.Accuracy of multidetector CT scans in staging of renal carcinoma[J]. International Journal of Surgery,2011,9(1):86-90.
  • 4Qing-Qiang Zhu,Zhong-Qiu Wang,Wen-Rong, et al.The multislice CT findings of renal carcinoma associated with XPll.2 translocation/TFE gene fusion and collecting duct carcinoma.[J].Acta Radiologica,2013,54(3):355 -362.
  • 5Kitajima,K.,Takahashi,S.,Maeda,T. et al.Thyroid size change by CT monitoring after sorafenib or sunitinib treatment in patients with renal cell carcinoma: Comparison with thyroid function[J].European Journal of Radiology,2012,81(9):2060-2065.
  • 6Stakhovskyi O, Yap SA, Leveridge M, et al. Small renal mass: what the urologist needs to know for treatment planning and assessment of treatment results[ J]. AJR Am J Roentgenol, 2011, 196 : 1267-1273.
  • 7Millet I, Doyon FC, Hoa D, et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? [ J]. A JR Am J Roentgenol, 2011, 197: 887-$96.
  • 8Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. Usefulness of diffusion-weighted imaging in the evaluation of renal masses[J].AJR Am J Roentgenol, 2010, 194: 438-445.
  • 9Wang H, Cheng L, Zhang X, et al. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T [ J]. Radiology, 2010, 257 : 135-143.
  • 10Inci E, Hoeaoglu E, Aydin S, et al. Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification[ Jl. Eur J Radiol, 2012, 81 : 815-820.

引证文献21

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部